I-MAB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.42 EUR | 0.00% |
|
-8.97% | -12.88% |
| 06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
dd1832a50225ea5cbb6ef5107d.OczFc4rJ1NqvgPFvMlz5xJEZDaWixMoMV58SYA6fT1I.XqeXQsuZ4p_etaZXAR6Oq_R2OcySk5I1MqtULFzULTpw9fAe1YeMlffylg~3df27f80df68f4732f82ab8eaafbbc32
